Palvella Therapeutics Files 8-K on Security Holder Vote Matters
Ticker: PVLA · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1583648
| Field | Detail |
|---|---|
| Company | Palvella Therapeutics, Inc. (PVLA) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, company-name-change
TL;DR
Palvella Therapeutics is holding a shareholder vote.
AI Summary
On June 10, 2025, Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.) filed an 8-K report detailing a submission of matters to a vote of security holders. The company, incorporated in Nevada, is in the pharmaceutical preparations industry and is headquartered in Wayne, Pennsylvania.
Why It Matters
This filing indicates that Palvella Therapeutics is engaging its shareholders in a decision-making process, which could lead to significant corporate actions or changes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not an indication of immediate financial distress or significant operational change.
Key Numbers
- 001-37471 — Commission File Number (Identifies the company's SEC filing history)
- 30-0784346 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Palvella Therapeutics, Inc. (company) — Registrant
- Pieris Pharmaceuticals, Inc. (company) — Former company name
- June 10, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Wayne, Pennsylvania (location) — Business address
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is being reported.
When was Palvella Therapeutics, Inc. formerly known as Pieris Pharmaceuticals, Inc.?
The date of the name change from Pieris Pharmaceuticals, Inc. to Palvella Therapeutics, Inc. is not explicitly stated in this excerpt, but the filing is dated June 11, 2025, and the former name is listed.
What is Palvella Therapeutics, Inc.'s industry?
Palvella Therapeutics, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
Where is Palvella Therapeutics, Inc. located?
The company's business address is 125 Strafford Ave, Suite 360, Wayne, Pennsylvania.
What is the significance of the 'Submission of Matters to a Vote of Security Holders' item?
This item indicates that the company is seeking approval or decisions from its shareholders on certain corporate actions or proposals.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding PALVELLA THERAPEUTICS, INC. (PVLA).